Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 20 | 0 | 20 |
| 1997 | 15 | 3 | 18 |
| 1998 | 5 | 3 | 8 |
| 1999 | 5 | 0 | 5 |
| 2000 | 23 | 6 | 29 |
| 2001 | 11 | 4 | 15 |
| 2002 | 12 | 5 | 17 |
| 2003 | 4 | 2 | 6 |
| 2004 | 16 | 4 | 20 |
| 2005 | 20 | 2 | 22 |
| 2006 | 24 | 3 | 27 |
| 2007 | 11 | 5 | 16 |
| 2008 | 19 | 6 | 25 |
| 2009 | 15 | 7 | 22 |
| 2010 | 20 | 4 | 24 |
| 2011 | 31 | 8 | 39 |
| 2012 | 22 | 7 | 29 |
| 2013 | 25 | 4 | 29 |
| 2014 | 38 | 6 | 44 |
| 2015 | 25 | 3 | 28 |
| 2016 | 32 | 5 | 37 |
| 2017 | 21 | 7 | 28 |
| 2018 | 26 | 7 | 33 |
| 2019 | 38 | 3 | 41 |
| 2020 | 16 | 8 | 24 |
| 2021 | 30 | 5 | 35 |
| 2022 | 39 | 1 | 40 |
| 2023 | 31 | 0 | 31 |
| 2024 | 24 | 5 | 29 |
| 2025 | 25 | 4 | 29 |
| 2026 | 21 | 6 | 27 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Clinical Profiles and Early Outcomes of Living Kidney Donors With Pre-Existing Type 2 Diabetes. Clin Transplant. 2026 10; 40(10).
-
Transcriptional and epigenomic analysis of insulin sensitivity in human adipocytes. Cell Rep. 2026 Oct 27; 45(10):118042.
-
Genetic factor analysis for characterizing phenome-wide patterns of genetic pleiotropy. Nat Genet. 2026 Oct; 58(10):2494-2501.
-
Digenic HNF1A and ABCC8 variants provide mechanistic insight into early-onset diabetes. J Clin Endocrinol Metab. 2026 Sep 16; 111(10):2827-2836.
-
Renal outcomes in people with type 2 diabetes with and without albuminuria treated with SGLT-2 inhibitors and GLP-1 receptor agonists: target trial emulation. BMJ. 2026 Sep 16; 394:e100574.
-
Association of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetes. Diabetes Res Clin Pract. 2026 Sep; 239:113503.
-
Insulin resistance and type 2 diabetes as allostatic responses to chronic nutrient excess. Cell Metab. 2026 Aug 04; 38(8):1540-1556.
-
Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes. Am J Kidney Dis. 2026 Sep; 88(3):366-377.
-
Genetic variants affect diurnal glucose levels throughout the day. Nat Commun. 2026 May 22; 17(1).
-
Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. BMJ Open Diabetes Res Care. 2026 May 21; 14(3).